z-logo
open-access-imgOpen Access
Planning of new heterocyclic compounds targeting class I PI3Ks for cancer therapy
Author(s) -
Júlio César de Araujo Vanelis Soares,
Luiza R.S. Dias,
Pamela Christabel Lima Thomas,
Luiza Calaza de Pinho,
Camilo Henrique da Silva Lima
Publication year - 2021
Publication title -
proceedings of 7th international electronic conference on medicinal chemistry
Language(s) - English
Resource type - Conference proceedings
DOI - 10.3390/ecmc2021-11482
Subject(s) - idelalisib , autodock , virtual screening , docking (animal) , chemistry , pi3k/akt/mtor pathway , stereochemistry , active site , combinatorial chemistry , computational biology , biochemistry , enzyme , biology , medicine , ibrutinib , signal transduction , immunology , in silico , nursing , chronic lymphocytic leukemia , pharmacophore , leukemia , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here